Faculty of Biology, Technion, Haifa, Israel.
Mol Cell Proteomics. 2011 Oct;10(10):O111.011833. doi: 10.1074/mcp.O111.011833. Epub 2011 Aug 2.
The time is ripe for staging the Human Immunopeptidome Project, whose goal is to analyze the full repertoires of peptides bound to the HLA molecules, in both health and disease. Mass spectrometry technologies have matured to enable comprehensive analyses of both the membrane-bound and the plasma soluble immunopeptidomes associated with each of the HLA allomorphs and the different diseases. The expected outcomes of such project will include basic understanding of the molecular mechanisms involved with formation of immunopeptidomes, correlating them with their source cellular proteomes, definition of both the consensus motifs and the scope of each allomorphs-specific immunopeptidomes, and most importantly, identification of disease-related HLA peptides, which may eventually serve as biomarkers or immunotherapeutics. Ideally, the Human Immunopeptidome Project will become public and the gathered data will be shared, as soon as possible. Other immunopeptidome projects, of other animals, will follow suit.
现在是时候启动人类免疫肽组学计划了,该计划的目标是分析健康和疾病状态下与 HLA 分子结合的肽的全部谱。质谱技术已经成熟,可以全面分析与每个 HLA 同种异型和不同疾病相关的膜结合和血浆可溶性免疫肽组。该项目的预期结果将包括对免疫肽组形成所涉及的分子机制的基本了解,将其与细胞蛋白质组相关联,定义共识基序和每个同种异型特异性免疫肽组的范围,最重要的是,确定与疾病相关的 HLA 肽,这些肽最终可能成为生物标志物或免疫治疗药物。理想情况下,人类免疫肽组学计划将尽快公开并共享所收集的数据。其他动物的免疫肽组学计划也将效仿。